| Ms Emily J Swenson, LICSW | |
|
1720 University Dr S, Fargo, ND 58103 | |
| (701) 461-5307 | |
| (701) 461-5312 |
| Full Name | Ms Emily J Swenson |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1720 University Dr S, Fargo, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366575250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 3603 (North Dakota) | Primary |
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
As part of the new health care reform, the federal government and 27 state governments are establishing temporary high-risk pools to offer coverage for people with pre-existing conditions until the law takes full effect in 2014.
When it comes to stopping illness, social media posts and tweets may be just what the doctor ordered. A Kansas State University-led research team is looking at social media as a tool to reduce and prevent diseases from spreading. Researchers are studying whether a well-timed post from a public authority or trustworthy person could be as beneficial as flu shots, hand-washing or sneezing into an elbow.
Massachusetts General Hospital investigators have found the probable mechanism underlying a previously described biomarker associated with the risk of developing serious diseases ranging from cancer to cardiovascular disease and the risk of serious complications. In a paper published in the American Journal of Hematology, the research team reports finding that higher levels of a measure routinely taken as part of the complete blood count - the extent of variation in the size of red blood cells - is caused by reduced clearance of aging cells from the bloodstream.
The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.
More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug sorafenib can reduce the size of large tumors and could be safely undertaken administered without adding significantly to the risks of surgery.
› Verified 6 days ago
| Entity Name | Innovis Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215125463 PECOS PAC ID: 9931298155 Enrollment ID: O20071211000158 |
News Archive
As part of the new health care reform, the federal government and 27 state governments are establishing temporary high-risk pools to offer coverage for people with pre-existing conditions until the law takes full effect in 2014.
When it comes to stopping illness, social media posts and tweets may be just what the doctor ordered. A Kansas State University-led research team is looking at social media as a tool to reduce and prevent diseases from spreading. Researchers are studying whether a well-timed post from a public authority or trustworthy person could be as beneficial as flu shots, hand-washing or sneezing into an elbow.
Massachusetts General Hospital investigators have found the probable mechanism underlying a previously described biomarker associated with the risk of developing serious diseases ranging from cancer to cardiovascular disease and the risk of serious complications. In a paper published in the American Journal of Hematology, the research team reports finding that higher levels of a measure routinely taken as part of the complete blood count - the extent of variation in the size of red blood cells - is caused by reduced clearance of aging cells from the bloodstream.
The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.
More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug sorafenib can reduce the size of large tumors and could be safely undertaken administered without adding significantly to the risks of surgery.
› Verified 6 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
As part of the new health care reform, the federal government and 27 state governments are establishing temporary high-risk pools to offer coverage for people with pre-existing conditions until the law takes full effect in 2014.
When it comes to stopping illness, social media posts and tweets may be just what the doctor ordered. A Kansas State University-led research team is looking at social media as a tool to reduce and prevent diseases from spreading. Researchers are studying whether a well-timed post from a public authority or trustworthy person could be as beneficial as flu shots, hand-washing or sneezing into an elbow.
Massachusetts General Hospital investigators have found the probable mechanism underlying a previously described biomarker associated with the risk of developing serious diseases ranging from cancer to cardiovascular disease and the risk of serious complications. In a paper published in the American Journal of Hematology, the research team reports finding that higher levels of a measure routinely taken as part of the complete blood count - the extent of variation in the size of red blood cells - is caused by reduced clearance of aging cells from the bloodstream.
The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.
More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug sorafenib can reduce the size of large tumors and could be safely undertaken administered without adding significantly to the risks of surgery.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Emily J Swenson, LICSW Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Ms Emily J Swenson, LICSW 1720 University Dr S, Fargo, ND 58103 Ph: (701) 461-5307 |
News Archive
As part of the new health care reform, the federal government and 27 state governments are establishing temporary high-risk pools to offer coverage for people with pre-existing conditions until the law takes full effect in 2014.
When it comes to stopping illness, social media posts and tweets may be just what the doctor ordered. A Kansas State University-led research team is looking at social media as a tool to reduce and prevent diseases from spreading. Researchers are studying whether a well-timed post from a public authority or trustworthy person could be as beneficial as flu shots, hand-washing or sneezing into an elbow.
Massachusetts General Hospital investigators have found the probable mechanism underlying a previously described biomarker associated with the risk of developing serious diseases ranging from cancer to cardiovascular disease and the risk of serious complications. In a paper published in the American Journal of Hematology, the research team reports finding that higher levels of a measure routinely taken as part of the complete blood count - the extent of variation in the size of red blood cells - is caused by reduced clearance of aging cells from the bloodstream.
The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.
More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug sorafenib can reduce the size of large tumors and could be safely undertaken administered without adding significantly to the risks of surgery.
› Verified 6 days ago
Rachel Marsolek, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 721 1st Ave N, Fargo, ND 58102 Phone: 701-461-7364 | |
Brittany Joy Alexander, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2101 Elm St N, Fargo, ND 58102 Phone: 701-232-3241 | |
Tracy E Mohn, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 4th St S, Fargo, ND 58103 Phone: 701-234-3106 Fax: 701-234-3106 | |
Rachel Salquist, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2101 Elm St N, Fargo, ND 58102 Phone: 701-232-3241 | |
Tracy M Foldesi-penas, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 4th St S, Fargo, ND 58103 Phone: 701-234-3100 Fax: 701-234-3120 | |
Lindsey Leigh Krueger, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 6046 14th St S, Fargo, ND 58104 Phone: 701-404-0997 Fax: 701-566-8876 | |
Deonne J Varriano, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2624 9th Ave S, Fargo, ND 58103 Phone: 701-298-4500 Fax: 701-298-4400 |